Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
CAS number: 1415456‑99‑3
Molecular weight: 4409.01 Da
COA (certificate of analysis) provided: Cagrilintide COA 99.38
Purity: 99.38% HPLC

Product Video:

Cagrilintide is a synthetic, lipidated analogue of amylin, the hormone co‑secreted with insulin. Its modifications make it long‑acting, allowing once‑weekly administration in research settings.
It is currently being evaluated in Phase 3 trials, especially in combination with semaglutide (“CagriSema”) for enhanced metabolic effects.
Key Mechanisms

Amylin receptor activation → increases satiety and reduces hunger

Calcitonin receptor co‑activation → enhances metabolic signalling

Slows gastric emptying → prolongs fullness after meals

Reduces glucagon secretion (outside hypoglycaemia)

Improves insulin sensitivity

Research‑Observed Benefits

Appetite suppression and reduced food intake

Weight‑management potential, especially when paired with semaglutide (22.7% weight loss in trials)

Better glycaemic control and improved metabolic markers

Once‑weekly dosing convenience due to extended half‑life.

Legal and Safety Information;
Quantum Peptides products are provided exclusively for laboratory research and educational use.
They are not approved for human or veterinary applications.
These materials are not intended to diagnose, treat, cure, or prevent any medical condition.
All use must adhere to applicable laws and regulatory requirements.

“The photo is for illustration purposes only and includes as much product information as possible. Bottle labels wrap around the container and may vary slightly in design & between batches as part of our anti‑counterfeiting measures.”